Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

Halle (Saale) / Munich, Germany, May 15, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will publish its first quarter financial results for the period ended March 31, 2024 and provide a corporate update on Thursday, May 23, 2024. The Company will host a conference call and webcast open to the public.

Conference call details
Date: May 23, 2024
Time: 3:00 pm CEST / 9:00 am EDT

The conference call will be available via phone and webcast.
The live audio webcast of the call will be available on Vivoryon´s website at: https://www.vivoryon.com/investors-news/news-and-events/presentations-webcasts/

To join the conference call via phone, participants may pre-register and will receive dedicated dial-in details to easily and quickly access the call via the following website:
https://register.vevent.com/register/BI9aadfa99e014435493eca917a11150f1

It is suggested participants dial into the conference call 15 minutes prior to the scheduled start time to avoid any delays in attendance.

###

About Vivoryon Therapeutics N.V.
Vivoryon is a clinical stage biotechnology company focused on developing innovative small molecule-based medicines. Driven by its passion for ground-breaking science and innovation, the Company strives to change the lives of patients in need suffering from severe diseases. The Company leverages its i…

### Simplifying legal Jargon with the AI legalese decoder
—

The **AI legalese decoder** is a revolutionary tool designed to simplify legal jargon and make complex legal documents easier to understand for the general public.

Using advanced natural language processing algorithms, the AI legalese decoder can analyze and break down intricate legal terms and phrases into simple, everyday language. By removing the barriers created by convoluted legal terminology, this tool aims to enhance accessibility to legal information and empower individuals to navigate legal documents with ease.

In the case of **Vivoryon Therapeutics N.V.**, the AI legalese decoder can assist in translating the intricate language used in the company’s financial reports and disclosures into clear and concise explanations. By providing simplified explanations of complex legal terms, the AI legalese decoder helps individuals better comprehend the content of such documents and make informed decisions.

Moreover, the AI legalese decoder serves as a valuable resource for individuals and businesses seeking to understand legal documents, ensuring clarity and transparency in legal communication. With the AI legalese decoder, decoding legal jargon has never been easier.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link